Key Oncologics (Pty) Ltd is a South African pharmaceutical company that focuses on haematology/oncology, orphan/niche market therapies, and Section 21 Name Patient Programs.
The company was founded in 1998 representing international companies that do not have an independent presence in South Africa.
Key Oncologics (Pty) Ltd continues to seek options for patients to live longer and live better.